drugset / Trial / NCT07420816
Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of APSTZD compared to one active drug and placebo in insomnia treatment.
Timeline
- Start
- 2026-03-26
- Primary completion
- 2027-09-23
- Completion
- 2027-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | APSTZD | Unknown | — | Oral |
| Comparator | Stilnox CR® | Unknown | — | Oral |